Alpha 2.0
Login Register
» Authors » Ching-Lung Liu

Ching-Lung Liu

Explore the profile of Ching-Lung Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 217
Followers 0
Related Specialties
Pulmonary Medicine
General Medicine
Neurology
Top 10 Co-Authors
Yen-Ta Lu
Hsu-Tah Kuo
Wu-Huei Hsu
Tsung-Ming Yang
Shih-Lung Cheng
Ming-Shian Lin
Pei-Jan Chen
Cheng-Yi Wang
Chien-Liang Wu
Kun-Ta Chou
Published In
Chest
J Emerg Med
J Formos Med Assoc
Int J Chron Obstruct Pulmon Dis
Respir Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO)
Lai Y, Tsai Y, Hsieh M, Chen N, Cheng S, Tao C, et al.
Respir Res . 2024 Oct; 25(1):377. PMID: 39420386
Background: Dual bronchodilator therapy, consisting of a long-acting beta-agonist (LABA) and a long-acting muscarinic antagonist (LAMA), has proven effective for patients with chronic obstructive pulmonary disease (COPD). However, it remains...
2.
Recommended assessment and management of sleep disordered breathing in patients with atrial fibrillation, hypertension and heart failure: Taiwan Society of Cardiology/Taiwan Society of sleep Medicine/Taiwan Society of pulmonary and Critical Care...
Lee P, Wu Y, Cheng H, Wang C, Chuang L, Lin C, et al.
J Formos Med Assoc . 2023 Sep; 123(2):159-178. PMID: 37714768
Sleep disordered breathing (SDB) is highly prevalent and may be linked to cardiovascular disease in a bidirectional manner. The Taiwan Society of Cardiology, Taiwan Society of Sleep Medicine and Taiwan...
3.
Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
Hsieh M, Chen N, Cheng S, Tao C, Wei Y, Wu Y, et al.
Int J Chron Obstruct Pulmon Dis . 2022 May; 17:967-976. PMID: 35510163
Background: Long-acting beta-agonists (LABA) and long-acting muscarinic antagonists (LAMA) combination therapy improved lung function and health-related quality-of-life and reduced exacerbation rates and dyspnea in symptomatic chronic obstructive pulmonary disease (COPD)...
4.
Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Chen C, Sheu C, Cheng S, Wang H, Lin M, Hsu W, et al.
Int J Chron Obstruct Pulmon Dis . 2021 Dec; 16:3405-3415. PMID: 34955636
Background And Aim: Chronic obstructive pulmonary disease (COPD) is frequently underdiagnosed because of the unavailability of spirometers, especially in resource-limited outpatient settings. This study provides real-world evidence to identify optimal...
5.
Experiences with pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension at multiple centers in Taiwan
Liu H, Wu Y, Huang S, Liu C, Hsu H, Yu C
J Formos Med Assoc . 2021 Aug; 121(3):604-612. PMID: 34373177
Background: Of the types of pulmonary hypertension, chronic thromboembolic pulmonary hypertension (CTEPH) may be cured through pulmonary endarterectomy (PEA). In this study, we investigated patient experiences with PEA for CTEPH...
6.
Novel App-Based Portable Spirometer for the Early Detection of COPD
Lin C, Cheng S, Wang H, Hsu W, Lee K, Perng D, et al.
Diagnostics (Basel) . 2021 Apr; 11(5). PMID: 33925463
Chronic obstructive pulmonary disease (COPD) is preventable and treatable. However, many patients remain undiagnosed and untreated due to the underutilization or unavailability of spirometers. Accordingly, we used Spirobank Smart, an...
7.
Large-scale assessment of consistency in sleep stage scoring rules among multiple sleep centers using an interpretable machine learning algorithm
Liu G, Lin T, Wu H, Sheu Y, Liu C, Liu W, et al.
J Clin Sleep Med . 2020 Sep; 17(2):159-166. PMID: 32964831
Study Objectives: Polysomnography is the gold standard in identifying sleep stages; however, there are discrepancies in how technicians use the standards. Because organizing meetings to evaluate this discrepancy and/or reach...
8.
Building a model to precisely target the responders of a novel intermittent negative air pressure device-with mechanism definition
Hung T, Liu T, Lu T, Wang Y, Chen T, Huang C, et al.
Sleep Med . 2020 Jun; 72:20-27. PMID: 32540633
Objective: Due to the complexity of obstructive sleep apnea syndrome (OSAS), engaging patients in the right treatment poses a constant challenge. A novel oral pressure therapy device, the intermittent negative...
9.
Fenofibrate Facilitates Post-Active Tuberculosis Infection in Macrophages and is Associated with Higher Mortality in Patients under Long-Term Treatment
Liu C, Lu Y, Tsai I, Wu L, Chien W, Chung C, et al.
J Clin Med . 2020 Jan; 9(2). PMID: 31991736
Background: Mycobacterium () is an intracellular pathogen that infects and persists in macrophages. This study aimed to investigate the effects of long-term fenofibrate treatment in patients with tuberculosis (TB), and...
10.
Proteomic profiles of bronchoalveolar lavage fluid from patients with ventilator-associated pneumonia by gel-assisted digestion and 2-D-LC/MS/MS
Lu Y, Han C, Wu C, Yu T, Chien C, Liu C, et al.
Proteomics Clin Appl . 2010 Dec; 2(9):1208-22. PMID: 21136918
Development of ventilator-associated pneumonia (VAP) imposes a significant financial burden to the health care system, yet the therapeutic decisions rely on the conventional, less sensitive microbiological examination. Characterization of proteins...